The Popularity of Marijuana Stocks
Here is why Marijuana stocks are becoming popular.
Author:Karan EmeryReviewer:Stefano MclaughlinFeb 24, 2021198.8K Shares4M Views
Future Of The Marijuana Industry In The US
According to Marijuana Hemp Stocks, marijuana stocks are as follows:
The categorization of marijuana comes under the US Drug Enforcement Administration (DEA). It is a restricted drug and is considered a mind-altering substance like LSD, heroin. Despite these facts, four US states have legalized it for recreational purposes and twenty-three states have legalized it for medical usage. Americans prefer to get this drug legalized and this has created a big hype among the politicians and government officials. Marijuana can undoubtedly be used in the medical field for the treatment of physical and mental ailments associated with some of the chronic diseases. The industry still faces many hurdles due to the probability of misuse it could do to the general people who use it only for recreational purposes.
Benefits To States
The legalization of marijuana has been advantageous for the states socially and economically.
Taking an example of the state of Colorado, there was a collection of taxes (licensing, taxation, and fee) of $13.9 million in 2014-15. In the next year, the figures attained an increment of 70% and the taxes of $23.7 million were collected. Apart from this benefit, the states have been benefited from the decline of the crime rate. A similar addition to taxes and decrement in crime rate was observed in Washington state also. This is the primary consideration of the states to consider the benefits related to marijuana for the savings of billions for the states.
Medical Uses Of Marijuana
The legalization of marijuana not only benefits the government by saving the funds, but it is also undoubtedly a great step for the public and private institutes to treat many chronic diseases. There are practical solutions confirming the efficacy of the drug in relieving physical pain due to chronic diseases and stabilizing mental balance. It can reduce the spreading of cancer and halts the progress of Alzheimer’s Disease which is a great achievement. There are also stats illustrating the combating symptoms of PTSD and other psychological issues among the veteran community. The private sector has led many companies to like to study the effects of THC (Tetra-Hydro-Cannabinol) for developing new treatments to give pain-relieving effects.
Futuristic Approach
Marijuana has many social, medicinal, and economic benefits. Before making an investment in the cannabis sector, it is important to understand the important points. It is a powerful drug having positive and negative sides and hence, comes under controversy. The medical uses of marijuana are still under the process of confirmation and the treatment of side-effects of chronic diseases like HIV infection, cancer therapy, and others, are treated by this drug at the low-mid level. Recreational marijuana could reduce the prices of this drug and the tax revenue figures for the state would gradually decrease with it.
To conclude, it would be too early to cite the experiences of the states which have legalized cannabis for medical or recreational use. The evidence is on the promising notes by far. The medical industry is still making in-depth researches for marijuana usage for chronic diseases and hence, the investments in the cannabis segment would be still speculative. Investors must hold on to the betting for the full federal legalization of marijuana for now.
Karan Emery
Author
Karan Emery, an accomplished researcher and leader in health sciences, biotechnology, and pharmaceuticals, brings over two decades of experience to the table. Holding a Ph.D. in Pharmaceutical Sciences from Stanford University, Karan's credentials underscore her authority in the field.
With a track record of groundbreaking research and numerous peer-reviewed publications in prestigious journals, Karan's expertise is widely recognized in the scientific community.
Her writing style is characterized by its clarity and meticulous attention to detail, making complex scientific concepts accessible to a broad audience. Apart from her professional endeavors, Karan enjoys cooking, learning about different cultures and languages, watching documentaries, and visiting historical landmarks.
Committed to advancing knowledge and improving health outcomes, Karan Emery continues to make significant contributions to the fields of health, biotechnology, and pharmaceuticals.
Stefano Mclaughlin
Reviewer
Stefano Mclaughlin is a Psychologist focused on mental health, emotional well-being, and healthcare policy. He studied Psychology and Public Health at the University of Massachusetts Amherst, gaining a deep understanding of the intersection between mental health and public policy.
Stefano's mission is clear: he aims to destigmatize mental health discussions, improve access to mental healthcare, and promote emotional well-being for all. Drawing from personal experiences with anxiety and depression, Stefano shares real stories to make mental health topics more relatable and less intimidating.
In addition to his advocacy work, Stefano enjoys delving into books, experimenting in the kitchen, and embarking on new adventures. These hobbies fuel his creativity and inspire fresh perspectives for his advocacy work.
Latest Articles
Popular Articles